Category Pharmaceuticals and Biotech
-
-
Nov 30, 2018Cutting Through the Industry 4.0 Paradigm: It's Not About Big Data, but How to Use Your Data, New Webinar Hosted by Xtalks
The life science industry has always been steps ahead when it comes to data collection and analysis. It's possible to argue it has been embracing 'Industry 4.0' methodology before the term existed. However, companies have also been aware of the pitfalls of 'big data' for over 40 years.
Read more -
Nov 28, 2018First Light Biosciences Develops Rapid Test for C. Difficile Toxin B. in Stool Samples
Results of Technical Study Presented at ASM Microbe 2018
Read more -
Oct 30, 2018
Recent Technological Advancements in Medical Communication, New Webinar Hosted by Xtalks
Join this webinar for a discussion of the most common medical communications business challenges and potential solutions. This event will also feature a live demonstration of how patient-centric medical communications technology can be leveraged to streamline and optimize medical inquiry fulfillment, adverse event reporting and product complaint management.
Read more -
Oct 11, 2018First Light Biosciences Announces Funding From Biomedical Advanced Research and Development Authority (BARDA)
A contract extension representing $10.7 million over two years
Read more -
Oct 2, 2018Purchase Power is Back in the Hands of Independent Pharmacies
Members Standing Together in Fighting Price Hikes
Read more -
Sep 21, 2018Dr. Bob Raffa Joins Bridge Therapeutics' Scientific Advisory Board Bringing Decades of Research and Experience
Pharmaceutical startup Bridge Therapeutics announces the addition of Dr. Bob Raffa as its newest Scientific Advisory Board member.
Read more -
Sep 14, 2018Latest Biologic Launch in Psoriasis, UCB's Cimzia, Having a Tough Time Getting Traction, But Developing a Presence in Dermatology May Lay Foundation for Bimekizumab in the Future
Janssen's Tremfya continues to post gains, but may soon face competition as Sun Dermatology readies for the launch of Ilumya (tildrakizumab), the second IL-23 inhibitor to be introduced in the U.S. market, according to a new report from Spherix Global Insights
Read more -
Aug 22, 2018Primate Research Firm Explores Blockchain Technology
Alpha Genesis initiative with important medical research implications
Read more -
Aug 21, 2018Masy BioServices to Distribute New Products
Masy, a leading provider of quality solutions for Life Sciences, is now offering precision products from SenseAnywhere and Insatech
Read more -
Jul 16, 2018Longevity Biotech Initiates Clinical Neuroinflammation Biomarker Study at the Department of Veterans Affairs to Investigate Immune Related Aspects of Parkinson's Disease With Continued Support From the Michael J. Fox Foundation
Study aims to identify novel blood-based inflammatory markers that can be used to both identify and stratify Parkinson's disease patients
Read more -
Jul 11, 2018Upcoming Xtalks Webinar: How the New FDA Drug-Drug Interaction Guidance Fits Within the Drug Development De-Risking Model
Pharmaceutical development is inherently risky. To develop a molecule that has a desired, efficacious, but safe, effect in humans is a remarkable achievement considering the statistics.
Read more -
Jul 11, 2018
Cryogenic Supply Chain Risk Management During Storage and Transportation of Reproductive Material, New Webinar Hosted by Xtalks
Earlier this year, two fertility clinics experienced liquid nitrogen tank failures and thousands of eggs and embryos were compromised. These two catastrophic incidents highlight the risks associated with the storage and transportation of human reproductive materials including sperm, eggs and embryos.
Read more -
Jun 26, 2018Continuous Growth in the Pharmaceutical Industry is Fueling the Growth of the Global Pharmaceutical Desiccant Market at 4.39% of CAGR by 2026
According to the new market research report launched by Inkwood Research, The Global Pharmaceutical Desiccant market was valued at nearly $127650 million in 2017 and is anticipated to reach around $188150 million by 2026, growing at an estimated CAGR of 4.39% during the forecast period 2018-2026.
Read more -
Jun 25, 2018Clinical Pipe Debuts Pharma's First EHR-to-EDC Integration App at DIA 2018
Clinical Pipe allows patient data to be exported directly from a clinical site's EHR and transferred into clinical research EDC.
Read more -
-
Jun 12, 2018First Influenza-Specific Neuraminidase Test Kit
InDevR's VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase in influenza vaccines
Read more -
Jun 5, 2018Rising Prevalence of Genetic Disorders Upswings the Global Crispr Market to Grow at 36.53% of CAGR by 2026
According to the new market research report launched by Inkwood Research, The Global CRISPR Market was valued around $ 500 million in 2017 and is anticipated to reach 8000 million by 2026, growing at an estimated CAGR of 36.53%, during the forecast period 2018-2026.
Read more
